Tudor Investment Corp’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-142,274
| Closed | -$188K | – | 1500 |
|
|
2024
Q3 | $188K | Hold |
142,274
| – | – | ﹤0.01% | 1418 |
|
|
2024
Q2 | $145K | Hold |
142,274
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q1 | $260K | Hold |
142,274
| – | – | ﹤0.01% | 1261 |
|
|
2023
Q4 | $176K | Hold |
142,274
| – | – | ﹤0.01% | 1347 |
|
|
2023
Q3 | $162K | Hold |
142,274
| – | – | ﹤0.01% | 1354 |
|
|
2023
Q2 | $130K | Hold |
142,274
| – | – | ﹤0.01% | 1413 |
|
|
2023
Q1 | $80K | Hold |
142,274
| – | – | ﹤0.01% | 1458 |
|
|
2022
Q4 | $82K | Sell |
142,274
-4,434
| -3% | -$2.56K | ﹤0.01% | 1445 |
|
|
2022
Q3 | $46K | Hold |
146,708
| – | – | ﹤0.01% | 1509 |
|
|
2022
Q2 | $52K | Sell |
146,708
-491
| -0.3% | -$174 | ﹤0.01% | 1486 |
|
|
2022
Q1 | $106K | Buy |
147,199
+134,622
| +1,070% | +$96.9K | ﹤0.01% | 1428 |
|
|
2021
Q4 | $28K | Buy |
+12,577
| New | +$28K | ﹤0.01% | 1548 |
|
|
2021
Q3 | – | Sell |
-51,044
| Closed | -$193K | – | 1504 |
|
|
2021
Q2 | $193K | Sell |
51,044
-127,826
| -71% | -$483K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $605K | Buy |
178,870
+3,091
| +2% | +$10.5K | 0.01% | 1049 |
|
|
2020
Q4 | $492K | Buy |
+175,779
| New | +$492K | 0.01% | 946 |
|
|
2018
Q2 | – | Sell |
-21,105
| Closed | -$201K | – | 1008 |
|
|
2018
Q1 | $201K | Buy |
+21,105
| New | +$201K | 0.01% | 856 |
|
|
2017
Q3 | – | Sell |
-12,155
| Closed | -$175K | – | 1053 |
|
|
2017
Q2 | $175K | Sell |
12,155
-5,622
| -32% | -$80.9K | 0.01% | 901 |
|
|
2017
Q1 | $164K | Sell |
17,777
-1,951
| -10% | -$18K | 0.01% | 1255 |
|
|
2016
Q4 | $205K | Buy |
19,728
+1,318
| +7% | +$13.7K | 0.01% | 1197 |
|
|
2016
Q3 | $167K | Sell |
18,410
-388
| -2% | -$3.52K | ﹤0.01% | 1271 |
|
|
2016
Q2 | $141K | Buy |
18,798
+300
| +2% | +$2.25K | ﹤0.01% | 1304 |
|
|
2016
Q1 | $167K | Buy |
+18,498
| New | +$167K | ﹤0.01% | 1304 |
|